改良HoLEP术式与TURP术式治疗良性前列腺增生的疗效及安全性观察

doi:10.3969/j.issn.1671-7171.2019.05.020

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To analyze the efficacy and safety of modified HoLEP and TURP in the treatment of benign prostatic hyperplasia. 【Methods】A retrospective analysis of 236 patients with benign prostatic hyperplasia who were admitted to our hospital from January to December 2018 and divided into two groups according to the treatment plan. Among them, 143 patients underwent holmium laser prostate removal (HoLEP), while the remaining 93 patients underwent conventional transurethral resection of the prostate (TURP). The maximum urinary flow rate (Qmax), residual bladder volume (RUV), overactive bladder symptom score (OABSS), international prostate symptom score (IPSS), and quality of life score (QOL) were analyzed before and 3 months after surgery. Perioperative related indicators and postoperative complications were recorded. 【Results】The operation time and the weight of resected tissue in the HoLEP group were significantly higher than those in the TURP group, however, the intraoperative blood loss, urinary catheter indwelling time and hospitalization time were significantly lower than those in the TURP group (P<0.05). After 3 months, 27.96% of patients in the TURP group had complications, and 10.49% of patients in the HoLEP group had complications; the difference was statistically significant (P<0.05). Compared to those before surgery, the Qmax, RUV, OABSS, IPSS and QOL of the two groups were improved after surgery(P<0.05). However, the differences between the groups were not statistically significant (P>0.05). 【Conclusion】HoLEP and TURP are equivalent to the clinical efficacy of benign prostatic hyperplasia. HoLEP has less damage, more safety and faster recovery after surgery.

Key words： Prostatic Hyperplasia/SU Prostatectomy/ME

Received: 27 November 2018

PACS:

R6973.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2019.05.020 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2019/V36/I5/894

[1] 黄亮. 良性前列腺增生激光治疗研究进展[J]. 现代泌尿外科杂志, 2013, 18(2):207-210.
[2] Larouche A, Beeker A, Schiffmann J, et al. Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study[J]. Can Urol Assoc, 2014, 8(6): 419-424.
[3] 廖春华, 徐伟, 王祥林, 等. 钬激光前列腺剜除术治疗良性前列腺增生症的疗效及安全性[J]. 吉林医学, 2016, 37(1):159-160.
[4] 刘齐贵, 李新, 麻伟青, 等. 经尿道钬激光前列腺剜除术治疗症状性前列腺增生症3162例分析[J]. 中华外科杂志, 2013, 51(2):123-126.
[5] Marszalek M, Ponholzer A,Pusman M, et al. Transurethral resection of the prostate[J]. Eur Urol Suppl, 2009, 8: 504-512.
[6] Kavanagh LE, Jack GS, Lawrentschuk N. Prevention and management of TURP-related hemorrhage[J].Nat Rev Urol,2011, 8 (9): 504-514.
[7] 杨玉恺, 李飞, 陆鲲, 等. 经尿道前列腺电切术与双极等离子前列腺切除术对良性前列腺增生患者性功能影响的对比研究[J]. 中国性科学, 2015, 24(7):5-7.
[8] Hashim H, Abrams P. Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard[J]. Eur Urol, 2015, 67(6): 1097-1098.
[9] RU SV, Gilling PJ. In 2013 holmium laser enucleation of the prostate (HoLEP) may be the new gold standard[J]. Curr Urol Rep, 2012, 13(6): 427-432.
[10] 吴波, 杨波, 周东言, 等. 经尿道前列腺等离子双极电切术与耻骨上经膀胱前列腺切除术治疗良性前列腺增生的疗效和安全性比较[J]. 中国现代医生, 2014,52(28):24-26.
[11] Elmansy H, Kotb A, Elhilali M. 2266 Holmium laser enucleation of theprostate(HoLEP): long term durability of clinical outcomes and complication rates over 10 years follow up in a large patient cohort[J].J Urology,2011, 185(4): 908.
[12] Gilling PJ, Wilson LC, King CJ,et al.Long-term results of a randomized trial comparing holmiun laser enucleation of the prostate and transurethral resection of the prostate:resules at 7 years[J].BJU Int,2012, 109(3): 408-411.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(1): 208-210.